These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1607767)

  • 21. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
    Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans.
    Nestler JE; Clore JN; Strauss JF; Blackard WG
    J Clin Endocrinol Metab; 1987 Jan; 64(1):180-4. PubMed ID: 2946716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans associated with polycystic ovary syndrome: clinical and laboratory features.
    Taketani Y; Mizuno M
    Horm Res; 1990; 33 Suppl 2():27-30. PubMed ID: 2095357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of severe hyperandrogenism, acanthosis nigricans and over diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management.
    Grisaru D; Azem F; Oren M; Bar-Am A; Inbar M; Lessing JB
    Gynecol Endocrinol; 1996 Oct; 10(5):337-41. PubMed ID: 8915663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Polycystic ovaraian syndrome and hyperinsulinemia].
    Xu L; Yue L; Tan S; Yang S; Qiu D; Kong Y; Han D; Hu R; Deng L; Li L; Zhang J
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):303-6. PubMed ID: 12600116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of insulin and hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome].
    Vasiljević M
    Srp Arh Celok Lek; 2000; 128(9-10):335-9. PubMed ID: 11255689
    [No Abstract]   [Full Text] [Related]  

  • 27. A practical approach to the diagnosis of polycystic ovary syndrome.
    Chang RJ
    Am J Obstet Gynecol; 2004 Sep; 191(3):713-7. PubMed ID: 15467530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
    Pignatelli D
    Front Horm Res; 2013; 40():158-70. PubMed ID: 24002412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired insulin degradation in a patient with insulin resistance and acanthosis nigricans.
    Ferrannini E; Muggeo M; Navalesi R; Pilo A
    Am J Med; 1982 Jul; 73(1):148-54. PubMed ID: 7046438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interrelationship between excessive levels of circulating androgens in blood and ovulatory failure.
    Parker CR; Mahesh VB
    J Reprod Med; 1976 Aug; 17(2):75-90. PubMed ID: 134158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM; Taylor AE; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency.
    Pang SY; Softness B; Sweeney WJ; New MI
    N Engl J Med; 1987 May; 316(21):1295-301. PubMed ID: 3472077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.
    Dunaif A; Graf M
    J Clin Invest; 1989 Jan; 83(1):23-9. PubMed ID: 2642919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.
    Zacchè MM; Caputo L; Filippis S; Zacchè G; Dindelli M; Ferrari A
    Gynecol Endocrinol; 2009 Aug; 25(8):508-13. PubMed ID: 19551544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acanthosis nigricans, hirsutism, insulin resistance and insulin receptor defect.
    Leme CE; Wajchenberg BL; Lerário AC; Goldman J; Borges JL
    Clin Endocrinol (Oxf); 1982 Jul; 17(1):43-9. PubMed ID: 6749340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism.
    Barbieri RL; Smith S; Ryan KJ
    Fertil Steril; 1988 Aug; 50(2):197-212. PubMed ID: 3294042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acanthosis nigricans, hyperandrogenism, insulin resistance and mixed hyperlipemia].
    Thivolet CH; Mauduit G; Canivet B; Garrel D; Tourniaire J; Thivolet J; Pugeat M
    Presse Med; 1988 Jul; 17(26):1355-9. PubMed ID: 2970081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting glucose/insulin ratio. An index to differentiate normo from hyperinsulinemic women with polycystic ovary syndrome.
    Parra A; Ramírez A; Espinosa de los Monteros A
    Rev Invest Clin; 1994; 46(5):363-8. PubMed ID: 7839016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis.
    Mor E; Zograbyan A; Saadat P; Bayrak A; Tourgeman DE; Zhang C; Stanczyk FZ; Paulson RJ
    Am J Obstet Gynecol; 2004 Jun; 190(6):1654-60. PubMed ID: 15284763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and endocrine profiles of 62 Malaysian women with polycystic ovary syndrome.
    Tan TT; Lui SK; Satgunasingam N; Khalid BA
    Med J Malaysia; 1989 Dec; 44(4):302-6. PubMed ID: 2520038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.